The cyclic pentapeptide d-arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice

Jeong Mo Kim, Yong Ho Lee, Cheol Ryong Ku, Eunjig Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The interaction between the chemokine stromal cell-derived factor 1 and its receptor CXCR4 plays an important role in GH production and cell proliferation in normal and tumorous pituitary somatotrope cells. Therefore, the chemokine receptor CXCR4 could be an attractive target for antitumor drugs in patients with acromegaly. A synthetic antagonist of CXCR4, cyclic pentapeptide d-Arg3FC131 (c[Gly1-d-Tyr2-d-Arg3-Arg4-Nal5]) significantly inhibited GH production and proliferation of GH3 somatotrope tumor cells in vitro. It also induced apoptosis of GH3 cells through activation of the caspase-3 pathway. Systemic administration of d-Arg3FC131 inhibited the growth of GH3 cell xenografts in immunodeficient nude mice by inducing apoptosis and suppressing the proliferation of tumor cells. These results indicate that d-Arg3FC131 might have potential for the treatment of pituitary tumors producing excess GH in patients with acromegaly.

Original languageEnglish
Pages (from-to)536-544
Number of pages9
JournalEndocrinology
Volume152
Issue number2
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Nude Mice
Apoptosis
Acromegaly
Growth
Neoplasms
Cell Proliferation
CXCR4 Receptors
Chemokine CXCL12
Dilatation and Curettage
Chemokine Receptors
Pituitary Neoplasms
Chemokines
Heterografts
Caspase 3
Antineoplastic Agents
Therapeutics

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

@article{21d5082f218946c798ef3a59289e3f9c,
title = "The cyclic pentapeptide d-arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice",
abstract = "The interaction between the chemokine stromal cell-derived factor 1 and its receptor CXCR4 plays an important role in GH production and cell proliferation in normal and tumorous pituitary somatotrope cells. Therefore, the chemokine receptor CXCR4 could be an attractive target for antitumor drugs in patients with acromegaly. A synthetic antagonist of CXCR4, cyclic pentapeptide d-Arg3FC131 (c[Gly1-d-Tyr2-d-Arg3-Arg4-Nal5]) significantly inhibited GH production and proliferation of GH3 somatotrope tumor cells in vitro. It also induced apoptosis of GH3 cells through activation of the caspase-3 pathway. Systemic administration of d-Arg3FC131 inhibited the growth of GH3 cell xenografts in immunodeficient nude mice by inducing apoptosis and suppressing the proliferation of tumor cells. These results indicate that d-Arg3FC131 might have potential for the treatment of pituitary tumors producing excess GH in patients with acromegaly.",
author = "Kim, {Jeong Mo} and Lee, {Yong Ho} and Ku, {Cheol Ryong} and Eunjig Lee",
year = "2011",
month = "2",
day = "1",
doi = "10.1210/en.2010-0642",
language = "English",
volume = "152",
pages = "536--544",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

The cyclic pentapeptide d-arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. / Kim, Jeong Mo; Lee, Yong Ho; Ku, Cheol Ryong; Lee, Eunjig.

In: Endocrinology, Vol. 152, No. 2, 01.02.2011, p. 536-544.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The cyclic pentapeptide d-arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice

AU - Kim, Jeong Mo

AU - Lee, Yong Ho

AU - Ku, Cheol Ryong

AU - Lee, Eunjig

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The interaction between the chemokine stromal cell-derived factor 1 and its receptor CXCR4 plays an important role in GH production and cell proliferation in normal and tumorous pituitary somatotrope cells. Therefore, the chemokine receptor CXCR4 could be an attractive target for antitumor drugs in patients with acromegaly. A synthetic antagonist of CXCR4, cyclic pentapeptide d-Arg3FC131 (c[Gly1-d-Tyr2-d-Arg3-Arg4-Nal5]) significantly inhibited GH production and proliferation of GH3 somatotrope tumor cells in vitro. It also induced apoptosis of GH3 cells through activation of the caspase-3 pathway. Systemic administration of d-Arg3FC131 inhibited the growth of GH3 cell xenografts in immunodeficient nude mice by inducing apoptosis and suppressing the proliferation of tumor cells. These results indicate that d-Arg3FC131 might have potential for the treatment of pituitary tumors producing excess GH in patients with acromegaly.

AB - The interaction between the chemokine stromal cell-derived factor 1 and its receptor CXCR4 plays an important role in GH production and cell proliferation in normal and tumorous pituitary somatotrope cells. Therefore, the chemokine receptor CXCR4 could be an attractive target for antitumor drugs in patients with acromegaly. A synthetic antagonist of CXCR4, cyclic pentapeptide d-Arg3FC131 (c[Gly1-d-Tyr2-d-Arg3-Arg4-Nal5]) significantly inhibited GH production and proliferation of GH3 somatotrope tumor cells in vitro. It also induced apoptosis of GH3 cells through activation of the caspase-3 pathway. Systemic administration of d-Arg3FC131 inhibited the growth of GH3 cell xenografts in immunodeficient nude mice by inducing apoptosis and suppressing the proliferation of tumor cells. These results indicate that d-Arg3FC131 might have potential for the treatment of pituitary tumors producing excess GH in patients with acromegaly.

UR - http://www.scopus.com/inward/record.url?scp=79951664559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951664559&partnerID=8YFLogxK

U2 - 10.1210/en.2010-0642

DO - 10.1210/en.2010-0642

M3 - Article

C2 - 21147876

AN - SCOPUS:79951664559

VL - 152

SP - 536

EP - 544

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -